These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 17148436

  • 1. Third activity of Bordetella adenylate cyclase (AC) toxin-hemolysin. Membrane translocation of AC domain polypeptide promotes calcium influx into CD11b+ monocytes independently of the catalytic and hemolytic activities.
    Fiser R, Masín J, Basler M, Krusek J, Spuláková V, Konopásek I, Sebo P.
    J Biol Chem; 2007 Feb 02; 282(5):2808-20. PubMed ID: 17148436
    [Abstract] [Full Text] [Related]

  • 2. Cyclic AMP-Elevating Capacity of Adenylate Cyclase Toxin-Hemolysin Is Sufficient for Lung Infection but Not for Full Virulence of Bordetella pertussis.
    Skopova K, Tomalova B, Kanchev I, Rossmann P, Svedova M, Adkins I, Bibova I, Tomala J, Masin J, Guiso N, Osicka R, Sedlacek R, Kovar M, Sebo P.
    Infect Immun; 2017 Jun 02; 85(6):. PubMed ID: 28396322
    [Abstract] [Full Text] [Related]

  • 3. Pore-forming and enzymatic activities of Bordetella pertussis adenylate cyclase toxin synergize in promoting lysis of monocytes.
    Basler M, Masin J, Osicka R, Sebo P.
    Infect Immun; 2006 Apr 02; 74(4):2207-14. PubMed ID: 16552051
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bordetella adenylate cyclase toxin mobilizes its beta2 integrin receptor into lipid rafts to accomplish translocation across target cell membrane in two steps.
    Bumba L, Masin J, Fiser R, Sebo P.
    PLoS Pathog; 2010 May 13; 6(5):e1000901. PubMed ID: 20485565
    [Abstract] [Full Text] [Related]

  • 6. Adenylate cyclase toxin translocates across target cell membrane without forming a pore.
    Osickova A, Masin J, Fayolle C, Krusek J, Basler M, Pospisilova E, Leclerc C, Osicka R, Sebo P.
    Mol Microbiol; 2010 Mar 13; 75(6):1550-62. PubMed ID: 20199594
    [Abstract] [Full Text] [Related]

  • 7. Residues 529 to 549 participate in membrane penetration and pore-forming activity of the Bordetella adenylate cyclase toxin.
    Roderova J, Osickova A, Sukova A, Mikusova G, Fiser R, Sebo P, Osicka R, Masin J.
    Sci Rep; 2019 Apr 08; 9(1):5758. PubMed ID: 30962483
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Transmembrane segments of complement receptor 3 do not participate in cytotoxic activities but determine receptor structure required for action of Bordetella adenylate cyclase toxin.
    Wald T, Osickova A, Masin J, Liskova PM, Petry-Podgorska I, Matousek T, Sebo P, Osicka R.
    Pathog Dis; 2016 Apr 08; 74(3):. PubMed ID: 26802078
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Retargeting from the CR3 to the LFA-1 receptor uncovers the adenylyl cyclase enzyme-translocating segment of Bordetella adenylate cyclase toxin.
    Masin J, Osickova A, Jurnecka D, Klimova N, Khaliq H, Sebo P, Osicka R.
    J Biol Chem; 2020 Jul 10; 295(28):9349-9365. PubMed ID: 32393579
    [Abstract] [Full Text] [Related]

  • 13. Oligomerization is involved in pore formation by Bordetella adenylate cyclase toxin.
    Vojtova-Vodolanova J, Basler M, Osicka R, Knapp O, Maier E, Cerny J, Benada O, Benz R, Sebo P.
    FASEB J; 2009 Sep 10; 23(9):2831-43. PubMed ID: 19417082
    [Abstract] [Full Text] [Related]

  • 14. Acylation of lysine 860 allows tight binding and cytotoxicity of Bordetella adenylate cyclase on CD11b-expressing cells.
    Masin J, Basler M, Knapp O, El-Azami-El-Idrissi M, Maier E, Konopasek I, Benz R, Leclerc C, Sebo P.
    Biochemistry; 2005 Sep 27; 44(38):12759-66. PubMed ID: 16171390
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.